Figures computed from official regulatory filings — methodology.
| Insider | Type | Value · USD | |
|---|---|---|---|
| OrbiMed Asia GP IV, L.P. | Other | — | SEC |
| Farzan Nima | OtherD | — | SEC |
| Sabzevari Helen | OtherD | — | SEC |
| GORDON CARL L | OtherD | — | SEC |
| GORDON CARL L | OtherD | — | SEC |
| Meltz Mark A | OtherD | — | SEC |
| Epperly Melissa B, | OtherD | — | SEC |
| GORDON CARL L | OtherD | — | SEC |
| Flaherty Keith T. | OtherD | — | SEC |
| Epperly Melissa B, | OtherD | — | SEC |
| GORDON CARL L | Other | — | SEC |
| OrbiMed Asia GP IV, L.P. | Other | — | SEC |
| MITCHELL DEAN J | OtherD | — | SEC |
| Flaherty Keith T. | Other | — | SEC |
| GORDON CARL L | Other | — | SEC |
| Foresite Capital Opportunity Fund V, L.P. | Other | — | SEC |
| Sabzevari Helen | OtherD | — | SEC |
| Tananbaum James B. | Other | — | SEC |
| Meltz Mark A | Other | — | SEC |
| Smaldone Alsup Laurie | OtherD | — | SEC |
| Smaldone Alsup Laurie | OtherD | — | SEC |
| Tananbaum James B. | OtherD | — | SEC |
| Farzan Nima | Other | — | SEC |
| Smaldone Alsup Laurie | OtherD | — | SEC |
| Flaherty Keith T. | OtherD | — | SEC |